Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-143.25%EBITDA Margin
VS
Market
Sector
Industry
History
$ 2.66Close
$ 2.45 - $ 65.4 52-Week Range
Ticker Information
Ticker
BIAFCompany Name
BIOAFFINITY TECHNOLOGIES INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQBIOAFFINITY TECHNOLOGIES INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BIAF - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -11M | -143.25% | $ 7.68M |
| 3/31/2025 | $ -9.03M | -102.47% | $ 8.81M |
| 12/31/2024 | $ -8.33M | -88.98% | $ 9.36M |
| 9/30/2024 | $ -7.74M | -82.61% | $ 9.37M |
| 6/30/2024 | $ -8.14M | -111.2% | $ 7.32M |
| 3/31/2024 | $ -7.92M | -160.32% | $ 4.94M |
| 12/31/2023 | $ -7.63M | -301.26% | $ 2.53M |
| 9/30/2023 | $ -7.04M | -2190.35% | $ 321.49K |
| 6/30/2023 | $ -8.85M | -36633.44% | $ 24.16K |
| 3/31/2023 | $ -6.82M | -119236.07% | $ 5.72K |
Key Performance Insights, Last 5 Years
- BIOAFFINITY TECHNOLOGIES INC's latest trailing twelve months (TTM) EBITDA % stands at 0%.
- Over the past 5 years, BIOAFFINITY TECHNOLOGIES INC's average EBITDA % has been -25075.24%.
- The median EBITDA % for BIOAFFINITY TECHNOLOGIES INC during this period was -160.32%
- BIOAFFINITY TECHNOLOGIES INC reached its highest EBITDA % over the past 5 years at -82.61%.
- The lowest EBITDA % recorded by BIOAFFINITY TECHNOLOGIES INC in the same timeframe -119236.07%
BIOAFFINITY TECHNOLOGIES INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for BIOAFFINITY TECHNOLOGIES INC is calculated as follows: EBITDA [ $ -5.32M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ] BIAF - EBITDA Margin, Last 5 years
-119236.07%
Minimum
Mar 31, 2023
-82.61%
Maximum
Sep 30, 2024
-25075.24%
Average
-160.32%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -74.33% |
| max | 97.24% |
| average | 16.2% |
| median | 14.74% |
| std | 26.73% |